Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1757 of 6351
-
New drug camoteskimab tested for Tough-to-Treat eczema
Disease control CompletedThis is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.
Phase 2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
New bandage could slash infection risk for kids in ICU
Prevention CompletedRandomised, single-blind clinical trial comparing chlorhexidine gluconate-impregnated transparent dressings versus conventional transparent dressings in the prevention of central venous catheter-related bloodstream infections (CVC-BSI) in paediatric patients admitted to a tertiar…
Sponsor: University of Seville • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
Genetic showdown: can full genome sequencing outsmart rare gut disease?
Diagnosis Recruiting nowThis study will seek to determine if whole genome sequencing (WGS) improves diagnostic rates, and outcomes for congenital diarrhea and enteropathy (CODE) patients. The investigator will enroll 180 patients in a randomized controlled study to either WGS or whole exome sequencing (…
Sponsor: Children's Hospital of Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New heart monitor aims to keep patients out of hospital
Disease control CompletedThe goal of this prospective, multicenter, single-arm, open-label clinical trial (Strategy TO Prevent Decompensated Heart Failure) is to evaluate the 6month incidence of heart failure hospitalization (HFH) and all cause mortality in patients managed with haemodynamically guided t…
Sponsor: Seerlinq s. r. o. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Balloon in the womb: new hope for babies with severe birth defect?
Disease control Recruiting nowThe purpose of this research is to gather information on the safety and effectiveness of a new procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO).
Sponsor: Rodrigo Ruano • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Sidewalks and streetlights: a new weapon against cancer?
Prevention OngoingThe goal of Cancer PRevention through Enhanced EnvironMenT (Cancer PREEMpT) is to test whether a comprehensive intervention that improves the neighborhood built and social environment can reduce community-level cancer risk in persistent poverty (PP) areas. Our overall hypothesis …
Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Can a supplement melt liver fat? a trial puts it to the test
Disease control CompletedThis randomized, double-blind, placebo-controlled, two-period crossover study evaluated the effects of GLUT-F, a nutraceutical formulation containing silibin-enriched silymarin, glutathione, and vitamin E delivered with Enterosoma® technology, in adults with metabolic dysfunction…
Sponsor: University of Bari • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a brace or tape stop ankle sprains in young hoop stars?
Disease control CompletedThe aim of this study was to compare the effects of an ankle brace, functional taping, and no prophylactic method on maximum inversion angle, inversion velocity, peroneus longus reaction time, and subjective perception of instability during a simulated inversion task in adolescen…
Sponsor: Escola Superior de Saude do Alcoitao • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New diabetes drug HR17031 could beat standard insulin in blood sugar control
Disease control CompletedThe aim of this trial is to confirm the efficacy of HR17031 in controlling glycaemia in Chinese subjects with type 2 diabetes mellitus inadequately controlled on oral antidiabetic agents
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a single burst of magnetic pulses lift depression in autism?
Symptom relief Recruiting nowThis study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potent…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Can acupuncture help rebuild muscle while fighting obesity?
Disease control OngoingSarcopenia is defined by the European Working Group on Sarcopenia in Older People (EWGSOP) as "a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, carrying a risk of adverse outcomes such as physical disability, fractures, falls, imp…
Sponsor: Ayşe Ukbe Baykut • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a hormone and a sleep aid prevent brain surgery in preemies?
Disease control Recruiting nowVery preterm infants are prone to numerous medical complications with lifelong impact. Amongst the most serious neurologically are white matter injury (WMI), intraventricular hemorrhage (IVH) and the subsequent progression to posthemorrhagic hydrocephalus (PHH). Currently, the on…
Phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Money and mind: can financial coaching ease mental health struggles after incarceration?
Disease control OngoingThis proposal will address financial wellbeing, an often overlooked but important factor impacting reentry for justice-involved people with mental health challenges, who are disproportionately Black and Latine. The project will change community level determinants by integrating f…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for stuffy noses: drug trial targets nasal polyps
Disease control Recruiting nowThe main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Smart oxygen machine could prevent dangerous levels in hospital patients
Disease control CompletedThis study is a multicenter randomized controlled trial to determine the effectiveness of a closed loop/autonomous oxygen titration system (O2matic PRO100) to maintain normoxemia (goal range SpO2 90-96%, target 93%) during the first 72 hours of acute injury or illness, compared t…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Wheelchair users with MS may gain strength and mobility through tailored exercise
Symptom relief Recruiting nowApproximately 50% of people with multiple sclerosis (MS) use a wheelchair within 30 years of the initial diagnosis. Wheelchair use in MS is often associated with fatigue as a consequence of muscle weakness. Indeed, fatigue, a prevalent consequence of MS, often becomes debilitatin…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New study tracks psoriasis drug in Real-World greek patients
Disease control OngoingPsoriasis is a skin disorder wherein skin cells multiply faster than normal, making the skin itchy and look patchy and red. It is caused by an overactive immune system where the body attacks healthy tissue by mistake. The impact of Psoriasis on quality of life can be significant,…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug combo targets Hard-to-Treat cancers with MTAP deletion
Disease control OngoingThis is a first-in-human Phase 1/2, multicenter, open-label study of S095035 as single-agent, or in combination with TNG462 in adult participants with advanced or metastatic solid tumors with homozygous deletion of MTAP who have failed to respond to or have progressed after at le…
Phase 1/2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief OngoingThis is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A (Proof-of-concept) and Part B (Dose-regimen Finding) will evaluate the safety and efficacy of various induction and maintenance dos…
Phase 2 • Sponsor: Apogee Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New pacemaker technique aims to protect heart function
Disease control OngoingConventional right ventricular pacing (RVP) has been associated with ventricular dyssynchrony and an increased risk of pacing-induced cardiomyopathy, which may lead to worse clinical outcomes. These adverse effects are more pronounced in patients with pre-existing left ventricula…
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC